Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A Randomized, Double-Blind, Phase 2 Study of the Effects of the Vaccine Vanutide Cridificar with QS-21 Adjuvant on Immunogenicity, Safety and Amyloid Imaging in Patients with Mild to Moderate Alzheimer's Disease.
J Prev Alzheimers Dis. 2016;3(4):192-201. doi: 10.14283/jpad.2016.118.
J Prev Alzheimers Dis. 2016.
PMID: 29199321
Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Individuals with Early Alzheimer's Disease: Amyloid Imaging Positron Emission Tomography and Safety Results from a Phase 2 Study.
van Dyck CH, Sadowsky C, Le Prince Leterme G, Booth K, Peng Y, Marek K, Ketter N, Liu E, Wyman BT, Jackson N, Slomkowski M, Ryan JM.
van Dyck CH, et al.
J Prev Alzheimers Dis. 2016;3(2):75-84. doi: 10.14283/jpad.2016.91.
J Prev Alzheimers Dis. 2016.
PMID: 29210443
Item in Clipboard
Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.
Hull M, Sadowsky C, Arai H, Le Prince Leterme G, Holstein A, Booth K, Peng Y, Yoshiyama T, Suzuki H, Ketter N, Liu E, Ryan JM.
Hull M, et al.
Curr Alzheimer Res. 2017;14(7):696-708. doi: 10.2174/1567205014666170117101537.
Curr Alzheimer Res. 2017.
PMID: 28124589
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite